Respiratory

Latest News

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond repeated surgeries to manage the rare condition.

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

Obstructive sleep apnea syndrome. | Image Credit: Chinnapong - stock.adobe.com
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies

August 13th 2025

Acute respiratory failure. | Image Credit: Selvi - stock.adobe.com
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment

August 9th 2025

Chronic respiratory disease. | Image Credit: Tipapat - stock.adobe.com
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries

August 4th 2025

Continuing Medical Education
View All
August 23rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 23rd 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 23rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 23rd 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
August 23rd 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
August 23rd 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
August 23rd 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

COVID-19 spike protein
October 12th 2020

First Case of COVID-19 Reinfection Detected in the US

Skylar Jeremias
The United States has its first reported of coronavirus disease 2019 (COVID-19) reinfection, in a young male patient with no underlying immune conditions.
Stethoscope superimposed on flag image
October 9th 2020

US Signs Deal With AstraZeneca to Develop, Make COVID-19 Antibody Treatment

Gianna Melillo
The Trump administration signed a $486 million agreement with AstraZeneca to develop a coronavirus disease 2019 (COVID-19) antibody treatment.
e-Cigarette Use Rises Among Young Adults Who Have Not Smoked Combustible Cigarettes, Study Finds
October 6th 2020

e-Cigarette Use Rises Among Young Adults Who Have Not Smoked Combustible Cigarettes, Study Finds

Rose McNulty
Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.
Trump to Be Discharged From Hospital Despite Continued COVID-19 Treatments
October 5th 2020

Trump to Be Discharged From Hospital Despite Continued COVID-19 Treatments

Laura Joszt, MA
About 3 days after being airlifted to the hospital to be treated for symptoms stemming from coronavirus disease 2019 (COVID-19) infection, the president is returning to the White House.
Experts Discuss Myths of COVID-19 and Clarify Misunderstandings
October 4th 2020

Experts Discuss Myths of COVID-19 and Clarify Misunderstandings

Laura Joszt, MA
During a 1-hour free webinar from MJH Life Sciences™’s COVID-19 Coalition, experts discussed various myths around the coronavirus disease 2019 (COVID-19) pandemic.
How Have Colleges, Universities Addressed the COVID-19 Pandemic?
September 30th 2020

How Have Colleges, Universities Addressed the COVID-19 Pandemic?

There were a myriad of factors considered when deciding how to reopen higher education institutions amid the COVID-19 pandemic, particularly in prioritizing the safety of students, faculty, and community members, as well as the quality of education delivered.
Moderna SARS-CoV-2 Vaccine Elicits Response in Older Adults
September 29th 2020

Moderna SARS-CoV-2 Vaccine Elicits Response in Older Adults

Allison Inserro
The study is part of Moderna’s larger trial to find a vaccine to prevent coronavirus disease 2019, which puts older adults, who have weaker immune responses, at a higher risk of more severe illness and death.
What We're Reading: US Boosts COVID-19 Test Distribution; Infection Risk Among Teenagers; Telehealth Waivers End
September 29th 2020

What We're Reading: US Boosts COVID-19 Test Distribution; Infection Risk Among Teenagers; Telehealth Waivers End

AJMC Staff
HHS said it will send 100 million rapid COVID-19 tests to states by year’s end; CDC says teens twice as likely to get coronavirus infection than young children; several private health insurers to stop waiving telehealth copays.
Combatting COVID-19 Misinformation
September 25th 2020

Combatting COVID-19 Misinformation

Laura Joszt, MA
Almost as fast as coronavirus disease 2019 (COVID-19) spread around the world, so has misinformation about the infectious disease. MJH Life Sciences™ will host a free webinar to get the facts from the experts.
Dr Victoria Smith on Experience Taking Part in a COVID-19 Vaccine Trial
September 24th 2020

Dr Victoria Smith on Experience Taking Part in a COVID-19 Vaccine Trial

By taking part in a coronavirus disease 2019 (COVID-19) vaccine trial, participants can provide their personalized experience, which may help protect future generations of similar race and socioeconomic background.
What We're Reading: CDC’s About-Face on COVID-19 as Airborne; HHS Revokes FDA's Rule-Making Authority; Flying During the Pandemic
September 21st 2020

What We're Reading: CDC’s About-Face on COVID-19 as Airborne; HHS Revokes FDA's Rule-Making Authority; Flying During the Pandemic

AJMC Staff
The CDC abruptly pulled guidance saying that COVID-19 is primarily spread via airborne transmission; HHS issues memo stating that the FDA no longer has the authority to sign any new rules on food, vaccines; a novel study examines risk of infection during a flight.
Multidisciplinary Discussion Benefits Diagnosis, Management of ILD, Study Finds
September 18th 2020

Multidisciplinary Discussion Benefits Diagnosis, Management of ILD, Study Finds

Jaime Rosenberg
Implementing a multidisciplinary discussion has positive implications for both the diagnosis and management of interstitial lung disease (ILD), according to study findings.
Concurrent Wildfire, Pandemic Hazards Test US Mental, Physical Health
September 15th 2020

Concurrent Wildfire, Pandemic Hazards Test US Mental, Physical Health

Gianna Melillo
As smoke from West Coast wildfires threatens to worsen outdoor air quality across the country, concerns of indoor air quality are mounting following reports on how insufficient ventilation systems facilitate aerosol spread of COVID-19.
Researchers Test Montelukast as Personalized Asthma Therapy
September 9th 2020

Researchers Test Montelukast as Personalized Asthma Therapy

Allison Inserro
Researchers wanted to see if children with a certain allele benefitted from receiving montelukast instead of long-acting beta-2 agonist/inhaled corticosteroid therapy.
Dr Anthony Fauci Discusses the Systemic Effects of COVID-19
September 7th 2020

Dr Anthony Fauci Discusses the Systemic Effects of COVID-19

While coronavirus disease 2019 (COVID-19) is largely a respiratory disease, it is actually a systemic disease that has a wide range of effects and postinfection sequelae that aren’t yet fully known, said Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Myopathies Linked to Worse Outcomes in Systemic Sclerosis
September 5th 2020

Myopathies Linked to Worse Outcomes in Systemic Sclerosis

AJMC Staff
For patients with systemic sclerosis, myopathy is a risk factor for worse outcomes and survival, according to a recent study.
Bioethicists Propose Measures for Equitable Distribution of COVID-19 Vaccine
September 3rd 2020

Bioethicists Propose Measures for Equitable Distribution of COVID-19 Vaccine

Allison Inserro
Nineteen bioethicists proposed a 3-phase plan for equitable distribution of a vaccine for coronavirus disease 2019 (COVID-19).
What We’re Reading: Vaccine Promised by End of Year; Fears of Reinfection; College Contingency Plans
August 28th 2020

What We’re Reading: Vaccine Promised by End of Year; Fears of Reinfection; College Contingency Plans

AJMC Staff
President Donald Trump promised a coronavirus disease 2019 (COVID-19) vaccine by the end of the year; COVID-19 survivors report anxiety over reinfection; colleges release COVID-19 testing and quarantine data.
What We're Reading: Efficacy of Moderna's Vaccine; FDA Clears $5 COVID-19 Rapid Test; DOJ Wants Nursing Home Data
August 27th 2020

What We're Reading: Efficacy of Moderna's Vaccine; FDA Clears $5 COVID-19 Rapid Test; DOJ Wants Nursing Home Data

AJMC Staff
Preliminary data find Moderna's COVID-19 vaccine effective in older adults; FDA authorizes use of $5 COVID-19 rapid test; the DOJ asks for nursing home data from 4 blue states.
Amid Controversy, HHS Defends Change in COVID-19 Testing Guidance
August 26th 2020

Amid Controversy, HHS Defends Change in COVID-19 Testing Guidance

Allison Inserro
Two days after the CDC changed its guidance on who should get tested for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), HHS said the move was not politically motivated.
Thunderclouds
August 16th 2020

ED Visits for Asthma, COPD Spike Before Thunderstorms Among Medicare Beneficiaries

Jaime Rosenberg
A long-term study of over 46 million Medicare beneficiaries found that emergency department (ED) visits for acute respiratory illnesses such as asthma or COPD sharply increased in the days before a major thunderstorm.
Kaiser Study: Severe Obesity Boosts Risk of COVID-19 Death, Especially for the Young
August 12th 2020

Kaiser Study: Severe Obesity Boosts Risk of COVID-19 Death, Especially for the Young

Mary Caffrey
A study in Annals of Internal Medicine shows severe obesity presents a greater risk of death from COVID-19 than related factors such as diabetes or hypertension.
Vaping a Risk Factor for COVID-19 in Teens, Young Adults
August 11th 2020

Vaping a Risk Factor for COVID-19 in Teens, Young Adults

Allison Inserro
The authors said the findings bring new urgency to efforts by policy makers, school officials, community leaders, and others to educate the public about the link between smoking and coronavirus disease 2019 (COVID-19).
Researchers Find HRCT Risk Prediction Model Helpful in Predicting RA-ILD Prognosis
August 8th 2020

Researchers Find HRCT Risk Prediction Model Helpful in Predicting RA-ILD Prognosis

Jaime Rosenberg
A risk prediction model based on high-resolution computed tomography (HRCT) variables outperformed other models when predicting mortality among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Unmet Needs in Chronic Fibrosing ILD With Progressive Phenotype
August 3rd 2020

Unmet Needs in Chronic Fibrosing ILD With Progressive Phenotype

Progressive Chronic Fibrosing ILD: Multidisciplinary Care
August 3rd 2020

Progressive Chronic Fibrosing ILD: Multidisciplinary Care

Challenges of Chronic Fibrosing ILD With Progressive Phenotype
August 3rd 2020

Challenges of Chronic Fibrosing ILD With Progressive Phenotype

Progressive Chronic Fibrosing ILD: Antifibrotic Agents
August 3rd 2020

Progressive Chronic Fibrosing ILD: Antifibrotic Agents

Past Management of Chronic Fibrosing ILD
August 3rd 2020

Past Management of Chronic Fibrosing ILD

Goals of Treating Chronic Fibrosing ILD With Progressive Phenotype
August 3rd 2020

Goals of Treating Chronic Fibrosing ILD With Progressive Phenotype

<1
...
8910111213141516
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo